Century Plyboards (I)

Similar documents
Century Plyboards (I) BUY

Tree House BUY. Poised for growth. Company update. Initiating coverage. 18 February 2015 Institutional Equities

Century Plyboards Ltd

Best in Class; Initiate with a BUY

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Century Plyboards (I) Limited

Century Plyboards (India)

Century Plyboards BUY. Equity Research INDIA. Rs171. Wood Panel. A comprehensive play on wood panels! Reason for report: Initiating coverage

Century Plyboards (India)

Century Plyboards India

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

Swiss Glascoat Equipments

Century Plyboards INITIATING COVERAGE

Religare Investment Call

CENTURY PLYBOARDS (I) LIMITED INVESTOR PRESENTATION, 2014

Symphony Ltd. RESULT UPDATE 31st October 2017

Company Overview. Financial Performance

Company Overview. Financial Performance

Capacity expansion to drive growth; Retain Buy

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely

Oriental Carbon & Chemicals Ltd.

Adani Ports & SEZ Rating: Target price: EPS:

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Company Overview. Financial Performance

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Capacity expansion to drive revenue and operating performance

Institutional Equities

Mahindra & Mahindra Ltd.

Company Overview. Industry Overview. Financial Performance

LARGE CAP & 1,970 BSE

Institutional Equities

Company Overview. Financial Performance

Company Overview. Financial Performance

Maruti Suzuki. Source: Company Data; PL Research

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

Jamna Auto Industries

Aditya Gears Ltd. BSE Scrip Code:

Key estimate revision. Year CY14 87,383 11,148 6, CY15E 1,20,126 17,838 9,

Fineotex Chemical Ltd

Amber Enterprises India Ltd

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

Dalmia Bharat Enterprises

Century Plyboards. Result Update UNDER REVIEW. Ply revenue surprise, so does low interest cost AMBIT INSIGHTS

Century Plyboards. BUY Result Update. Better-than-expected results but requires clarity AMBIT RESULTS INSIGHTS

Cummins India Ltd Bloomberg Code: KKC IN

ITC. Rating: Target price: EPS: Relative better visibility despite the smoke, Maintain BUY CMP. Target. Rating. Rs.389. Buy. Rs.

India Cements Rating: Target price:

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Century Plyboards India Ltd.

Mahindra & Mahindra Ltd.

Company Overview. Financial Performance

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Company Overview. Financial Performance

Initiating Coverage. Uflex Ltd.

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Company Overview. Financial Performance

Indian Oil Corporation

Company Overview. Industry Overview. Financial Performance

Mahindra & Mahindra Ltd.

Q1FY19 Result Update. July 16, Prakash Industries (Steel & PVC Pipes) Q4FY18 result update BUY

Lippi Systems Ltd BSE Scrip Code:

Greenply Industries Ltd. Result Presentation - Q3 & 9M FY15

Century Plyboards (I) Ltd. Analyst Presentation Q3-FY 2011 Result Update

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

Stylam Industries Ltd Sector Industry

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Bharat Forge. Result Update. Q4FY13 Result Highlights. Valuation. No Respite in Sight May 29, Institutional Research 1

Century Plyboards (I) Ltd

Dr Reddy s Laboratories

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport

EBITDA 5,076 3, , EBITDA

Gillette India. Institutional Equities. 1QFY18 Result Update

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

Ramco Cement. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.415. Rs. 360

Institutional Equities

Emkay. Demand environment remain weak. Century Plyboards. Result highlights. Slowdown in plywood segment impacted revenue growth

Q4 EARNINGS REPORT Welspun India 25 Apr 17

FLASH NOTE Welspun India 31 Jan 17

Company Overview. Financial Performance

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

Colgate-Palmolive India Ltd.

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536

Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods

Skipper Ltd. May 17, Towering high. CMP INR 205 Target INR 238 Result Update - BUY. Company Background. Investment Rationale

Quarterly results (YE Mar) 4QFY13 4QFY14 YoY(%) FY13 FY14 YoY(%)

KDDL (KDDL IN) In expansion mode

Company Overview. Industry Overview. Financial Performance

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

Advisory Desk. TVS Srichakra Ltd. BUY CMP. `355 Target Price `468. Investment rationale. Outlook and valuation. Investment Period 12 Months

Star Ferro & Cement (STAFER) 113

Quick take. VIP Industries BUY. Travelling smart on the luggage track. CMP Target Price `153 ` year daily price chart

Reliance Industries. Timing is everything BUY COMPANY UPDATE 1 OCT 2014

Colgate-Palmolive (India)

JK Lakshmi Cement. Source: Company Data; PL Research

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1%

Volant Textile Mills Ltd BSE Scrip Code:

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

Visaka Industries Ltd

Transcription:

Leading branded plywood player Visit note - Not rated 19 June 2014 Institutional Equities Century Plyboard (CPBI), India s leading plywood manufacturer with the highest-selling plywood brand, expects housing sector push by the new government to boost demand growth for the industry. Indian plywood and panel market is estimated at Rs150bn with the share of organised players at Rs45bn. CPBI is a dominant player with 25% share in the organised market. CPBI expects revenue growth for organised players at 25-30% over the next few years. Reduction in excise duty in the past few years, a strong brand and quality awareness, and economies of scale have resulted in organized players growing at more than thrice the rate of unorganised players. CPBI is the first to set up a unit in Myanmar, which has ensured uninterrupted supply of quality raw materials to all its units (Myanmar has banned export of raw timber w.e.f 1 st April 2014). ROE improvement in FY14 was reduced due to huge forex loss of Rs440m because of INR depreciation. We expect the likely economic revival to boost the housing segment, which has been sluggish for the past two years. CPBI, a plywood player with strong brand recall, is poised to benefit from likely improvement in demand as it has expanded its capacity by 70% in the last two years. The stock is available at 26x PER on FY14 earnings. IIFL s score-card for unrated companies Key Positives Score of 1 5 Key Risks Score of 1 5 (with 5 as most positive) (with 5 as most risky) Industry growth potential Regulatory Dominant position within the industry Balance sheet strength, profitability ratios Execution track record of management Corporate Governance Competition (including possible foreign) Liquidity (trading volume) CMP Rs77 Market cap (US$m) 285 Enterprise value(us$m) 357 Bloomberg Sector CPBI IN Mid caps Shareholding pattern (%) Promoter 74.5 FII 0.9 DII 0.0 Others 24.6 52Wk High/Low (Rs) 78/22 Shares o/s (m) 222 Daily volume (US$ m) 1.1 Dividend yield FY13ii (%) 1.3 Free float (%) 27.1 Price performance (%) 1M 3M 1Y Absolute (Rs) 66.2 204.7 187.6 Absolute (US$) 62.5 210.3 179.2 Rel. to Sensex 60.4 187.7 155.5 Cagr (%) 3 yrs EPS 2.8 Stock performance Shares (000') 10,000 8,000 6,000 4,000 2,000 0 Volume (LHS) Price (RHS) Jun 12 Aug 12 Oct 12 Dec 12 Feb 13 Apr 13 Jun 13 Aug 13 Oct 13 Dec 13 Feb 14 Apr 14 Jun 14 Financial summary (Rs m) Revenues (Rs m) 9,309 11,183 11,311 12,840 Ebitda margins (%) 10.4 12.4 10.0 11.5 Pre exceptional PAT (Rs m) 745 733 527 669 Reported PAT (Rs m) 745 601 527 669 Pre exceptional EPS (Rs) 3.3 3.2 2.4 3.0 Growth (%) (8.0) (1.6) (26.6) 27.1 PER (x) 23.5 23.9 32.6 25.6 ROE (%) 29.4 24.8 18.7 24.7 Net debt/equity (x) 0.7 1.0 1.5 1.5 EV/Ebitda (x) 20.2 14.8 18.5 14.5 Price/book (x) 6.3 5.6 6.9 5.9. Priced as on 17 June 2014 (Rs) 80 60 40 20 0 J Radhakrishnan 91 22 4646 4653

Background CPBI is India s leading plywood manufacturing company with six manufacturing units in India and one in Myanmar. In India, it has plants in Haryana in north, Tamil Nadu in south, West Bengal in east, Assam in north-east, Gujarat in west, and Uttarakhand in the central region. CPBI is promoted by first-generation promoters. Mr. Sajjan Bhajanka and Mr. Sanjay Agarwal are the key promoters. Mr. Vishnu Khemani, Mr. Prem Bhajanka and Mr. H.P Agarwal are the other promoters. All promoters are first-generation entrepreneurs with over 30 years of experience in plywood and related products. CPBI s other two major business segments are laminates and logistics. CPBI is India s third largest laminate producer; laminates accounted for 19% of CPBI s revenue in FY14. CPBI recently has doubled laminate capacity from 2.4m sheets to 4.8m sheets. Figure 2: Ebitda mix FY14 Source: Company Plywood 74% Laminate 12% Logistic 14% CPBI operates two container freight stations near Kolkata Port area (0.1 m sqm); CFS operations were started in FY09. This is the first privately owned CFS in eastern India. Figure 1: Revenue mix FY14 CPBI entered the furniture business in 2012 with two pilot retail showrooms in Kolkata and Bengaluru. CPBI recently introduced modular kitchen made of plywood with all-proof warranty. CPBI plans to expand the retail furniture business through a franchisee model. CPBI also entered into trading in plywood related chemicals, glues and resins. Plywood 76% Laminate 18% Logistic 4% Others 2% Management Name Sajjan Bhajanka HariPrasad Agarwal Sanjay Agarwal Designation Chairman Vice Chairman Managing Director Source: Company 2

Leading plywood producer in India: CPBI is India s leading plywood producer with the highest volume and revenue. The close competitor for CPBI is Greenply, also a nation-wide player, whose market share is close to that of CPBI. CPBI and Greenply dominate the organised plywood market with ~50% market share; other organised players are regional (5-6 players). CPBI commands 5% premium over the nearest brand and 20% over products of unorganised players. Strong revenue and Ebitda growth despite sluggish economy: CPBI s revenue and Ebitda grew at 16% Cagr over FY10-FY14 driven by improved demand for organized sector products and brand recall for CPBI. CPBI has focused on brand building and has spent more than Rs2.2bn on brand building in the past 10 years; currently CPBI s spending brand building spend forms 4% of revenue; the management expects to maintain the current percentage of ad spending to boost revenue. PAT declined for FY10-FY14 period due to reduction in other income as the cement and ferro alloys businesses were hived off into a separate company. Figure 3: Revenue and growth trend 14,000 13,000 12,000 Revenues (LHS) Growth (RHS) (Rs m) (%) 35.0 30.0 25.0 Figure 4: Ebitda and growth trend 1,500 1,400 1,300 1,200 1,100 1,000 900 800 Ebitda (LHS) Growth (RHS) (Rs m) (%) FY11 FY12 FY13 FY14 50.0 40.0 30.0 20.0 10.0 0.0 (10.0) (20.0) Recovery in economy likely to boost revenue growth: With formation of strong and stable government, management expects improvement in housing demand and revival in plywood demand. While the industry is likely to clock 10-11% revenue growth, revenue of organized players is expected to grow at 25-30%; the unorganised segment is on a declining trend due to reducing duty differences and preference for products with better and consistent quality. Implementation of GST is likely to boost growth substantially for CPBI. 11,000 10,000 9,000 8,000 7,000 FY11 FY12 FY13 FY14 20.0 15.0 10.0 5.0 0.0 Capacity expansion in place to tap demand growth: CPBI has increased its plywood capacity from 0.125m cbm to 0.21m cbm in the past two years through greenfield expansion in Kandla, Gujarat and expansion in Myanmar. Overall utilisation for plywood in FY14 was ~70%. In laminates too, CPBI doubled its capacity to 4.8m sheets in the past two years. CPBI continues to focus on delivery systems by opening new depots regularly. It has implemented SAP to provide better service to customers. 3

Figure 5: Plywood capacity trend 250,000 (cbm) 200,000 150,000 100,000 50,000 Figure 6: ROE trend for CPBI 40 35 30 25 20 15 (%) 0 FY11 FY12 FY13 FY14 High entry barriers: In India cutting of matured timber is not allowed or is subject to stringent regulations. License is available only for imported raw material-based units and due to this the industry is heavily dependent on import of matured timber (primarily from Myanmar). With Myanmar banning export of raw timber w.e.f. 1 st April 2014, unorganised players are at a disadvantage compared with CPBI. CPBI is the first player from India to set up a unit in Myanmar, thus ensuring uninterrupted supply of quality raw material to all its units. Strong return ratios despite downturn; likely demand growth to boost ratios from here on: CPBI recorded 25% ROE in FY14 despite low utilisation due to sluggish economy. With major capex completed and capacity available to increase revenue at >25% for the next two years, return ratios are likely to expand going forward. CPBI spent Rs410m for 31000 cbm / annum capacity in Kandla, Gujarat in FY14 and expects annual revenue of Rs2bn from this expansion with likely payback period of two years. ROE improvement in FY14 was reduced due to huge forex loss of Rs440m because of INR depreciation. If the recent INR appreciation trend continues, ROE could see a strong bounce back in FY15. 10 FY10 FY11 FY12 FY13 FY14 Cement and ferro alloys subsidiary hived off: CPBI hived off the cement and ferro alloys businesses in its subsidiaries into a separate company through a scheme of arrangement in FY13 whereby every share of CPBI was given one share in the demerged new company. PAT Cagr is negative for FY10-FY14 largely due to a decline in other income due to nil dividend receipts from these businesses from FY13. Balance sheet strength likely to improve going forward: Due to huge capex and low profitability, net debt to equity has increased in the last two years. With likely improvement in profitability and no major capex in the near term, we expect the management to focus on reducing debt. 4

Financial summary Income statement summary (Rs m) Revenues 9,309 11,183 11,311 12,840 Ebitda 967 1,385 1,128 1,482 Depreciation and amortisation (242) (265) (267) (332) Ebit 725 1,120 861 1,150 Non operating income 160 41 73 95 Financial expense (128) (400) (390) (551) PBT 758 762 544 693 Exceptionals 0 (132) 0 0 Reported PBT 758 630 544 693 Tax expense (13) (29) (17) (24) PAT 745 601 527 669 Minorities, Associates etc. 0 0 0 0 Attributable PAT 745 601 527 669 Ratio analysis Per share data (Rs) Pre exceptional EPS 3.3 3.2 2.4 3.0 DPS 1.0 1.0 0.3 1.0 BVPS 12.2 13.7 11.2 13.1 Growth ratios (%) Revenues 31.5 20.1 1.1 13.5 Ebitda 16.1 43.3 (18.6) 31.3 EPS (8.0) (1.6) (26.6) 27.1 Profitability ratios (%) Ebitda margin 10.4 12.4 10.0 11.5 Ebit margin 7.8 10.0 7.6 9.0 Tax rate 1.7 4.6 3.2 3.4 Net profit margin 8.0 5.4 4.7 5.2 Return ratios (%) ROE 29.4 24.8 18.7 24.7 ROCE 19.3 20.4 13.9 17.3 Solvency ratios (x) Net debt equity 0.7 1.0 1.5 1.5 Net debt to Ebitda 2.1 2.1 3.3 2.9 Interest coverage 5.7 2.8 2.2 2.1 Source: Company data, IIFL Research Balance sheet summary (Rs m) Cash & cash equivalents 109 421 797 180 Inventories 1,712 1,967 2,177 2,927 Receivables 1,208 1,667 1,816 2,046 Other current assets 945 518 612 625 Creditors 1,122 869 808 742 Other current liabilities 275 440 598 1,037 Net current assets 2,577 3,264 3,996 3,999 Fixed assets 1,759 2,107 2,217 2,307 Intangibles 0 0 0 0 Investments 556 732 156 379 Other long term assets 0 409 605 701 Total net assets 4,892 6,512 6,974 7,386 Borrowings 2,110 3,390 4,479 4,478 Other long term liabilities (2) (4) (2) (5) Shareholders equity 2,784 3,125 2,497 2,914 Total liabilities 4,892 6,512 6,974 7,386 Cash flow summary (Rs m) Ebit 725 1,120 861 1,150 Tax paid (106) (135) (98) (112) Depreciation and amortization 242 265 267 332 Net working capital change (437) (375) (355) (620) Other operating items 52 (146) 123 13 Operating cash flow before interest 477 728 798 763 Financial expense (128) (400) (390) (551) Non operating income 160 41 73 95 Operating cash flow after interest 509 370 481 306 Capital expenditure (429) (641) (689) (482) Long term investments (52) (176) 576 (223) Others (167) (35) (1,271) (386) Free cash flow (139) (483) (903) (784) Equity raising 0 0 0 0 Borrowings 148 1,301 1,280 224 Dividend (56) (507) (1) (57) Net chg in cash and equivalents (46) 312 376 (617) Source: Company data, IIFL Research 5

Published in 2014, India Infoline Ltd 2014 This research report was prepared by India Infoline Limited s Institutional Equities Research Desk ( IIFL ), a company authorized to engage in securities activities in India. IIFL is not a registered brokerdealer in the United States and, therefore, is not subject to U.S. rules regarding the preparation of research reports and the independence of research analysts. This research report is provided for distribution to major U.S. institutional investors in reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the Exchange Act ). Any U.S. recipient of this research report wishing to effect any transaction to buy or sell securities or related financial instruments based on the information provided in this research report should do so only through IIFL Capital Inc ( IIFLCAP ), a registered broker dealer in the United States. IIFLCAP accepts responsibility for the contents of this research report, subject to the terms set out below, to the extent that it is delivered to a U.S. person other than a major U.S. institutional investor. The analyst whose name appears in this research report is not registered or qualified as a research analyst with the Financial Industry Regulatory Authority ( FINRA ) and may not be an associated person of IIFLCAP and, therefore, may not be subject to applicable restrictions under FINRA Rules on communications with a subject company, public appearances and trading securities held by a research analyst account. IIFL has other business units with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. This report is for the personal information of the authorized recipient and is not for public distribution. This should not be reproduced or redistributed to any other person or in any form. This report is for the general information of the investors, and should not be construed as an offer or solicitation of an offer to buy/sell any securities. We have exercised due diligence in checking the correctness and authenticity of the information contained herein, so far as it relates to current and historical information, but do not guarantee its accuracy or completeness. The opinions expressed are our current opinions as of the date appearing in the material and may be subject to change from time to time without notice. IIFL or any persons connected with it do not accept any liability arising from the use of this document. The recipients of this material should rely on their own judgment and take their own professional advice before acting on this information. IIFL or any of its connected persons including its directors or subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained, views and opinions expressed in this publication. IIFL and/or its affiliate companies may deal in the securities mentioned herein as a broker or for any other transaction as a Market Maker, Investment Advisor, etc. to the issuer company or its connected persons. IIFL generally prohibits its analysts from having financial interest in the securities of any of the companies that the analysts cover. In addition, the company prohibits its employees from conducting Futures & Options transactions or holding any shares for a period of less than 30 days. Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. Information, opinions and estimates contained in this report reflect a judgment of its original date of publication by IIFL and are subject to change without notice. The price, value of and income from any of the securities or financial instruments mentioned in this report can fall as well as rise. The value of securities and financial instruments is subject to exchange rate fluctuation that may have a positive or adverse effect on the price or income of such securities or financial instruments. Analyst Certification: (a) that the views expressed in the research report accurately reflect such research analyst's personal views about the subject securities and companies; and (b) that no part of his or her compensation was, is, or will be directly or indirectly related to the specific recommendation or views contained in the research report. Key to our recommendation structure BUY - Absolute - Stock expected to give a positive return of over 20% over a 1-year horizon. SELL - Absolute - Stock expected to fall by more than 10% over a 1-year horizon. In addition, Add and Reduce recommendations are based on expected returns relative to a hurdle rate. Investment horizon for Add and Reduce recommendations is up to a year. We assume the current hurdle rate at 10%, this being the average return on a debt instrument available for investment. Add - Stock expected to give a return of 0-10% over the hurdle rate, i.e. a positive return of 10%+. Reduce - Stock expected to return less than the hurdle rate, i.e. return of less than 10%. Distribution of Ratings: Out of 180 stocks rated in the IIFL coverage universe, 103 have BUY ratings, 4 have SELL ratings, 35 have ADD ratings, 1 have NR and 37 have REDUCE ratings. Price Target: Unless otherwise stated in the text of this report, target prices in this report are based on either a discounted cash flow valuation or comparison of valuation ratios with companies seen by the analyst as comparable or a combination of the two methods. The result of this fundamental valuation is adjusted to reflect the analyst s views on the likely course of investor sentiment. Whichever valuation method is used there is a significant risk that the target price will not be achieved within the expected timeframe. Risk factors include unforeseen changes in competitive pressures or in the level of demand for the company s products. Such demand variations may result from changes in technology, in the overall level of economic activity or, in some cases, in fashion. Valuations may also be affected by changes in taxation, in exchange rates and, in certain industries, in regulations. Investment in overseas markets and instruments such as ADRs can result in increased risk from factors such as exchange rates, exchange controls, taxation, and political and social conditions. This discussion of valuation methods and risk factors is not comprehensive further information is available upon request. 6